Human Dental Pulp Stromal Cells (hDPSCs) of neural-ectodermal origin hold immunomodulatory properties which make them a source for MSC-based therapies for the treatment of autoimmune diseases. Our results highlighted that hDPSCs exposed to different inflammatory conditions activate Fas/FasL and PD1/PD-L1 pathways. Moreover, hDPSCs modulate inflammatory cytokines release of aPBMCs from Rheumatoid Arthritis (RA) patients. However, the inflammatory milieu induced the upregulation of IL-6 by hDPSCs, which was demonstrated to be strongly correlated to PD-L1 expression, suggesting its involvement in supporting their immunoregulation. Our data demonstrated that the activation of the IL6/JAK/STAT3 trans-signaling pathway in hDPSCs through stimulation with the IL6/sIL6R complex leads to an increase in PD-L1 protein levels, but not PD-L2, via proteasome inhibition. The activation of the IL-6/PD-L1 axis in response to inflammatory conditions underscores its potential significance in autoimmune diseases since a dysfunction of this mechanism could lead to the onset and progression of chronic inflammatory disorders.
Immunomodulatory properties of human dental pulp stromal cells: the role of IL-6/JAK/STAT3 pathway and PD-L1 / Di Tinco, Rosanna; Pisciotta, Alessandra; Bertani, Giulia; Orlandi, Giulia; Bertoni, Laura; Pignatti, Elisa; Bonacini, Martina; Rossi, Alessandro; Roelofs, Anke J.; Croci, Stefania; De Bari, Cosimo; Salvarani, Carlo; Carnevale, Gianluca. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 17:(2026), pp. 1-30. [10.3389/fimmu.2026.1713704]
Immunomodulatory properties of human dental pulp stromal cells: the role of IL-6/JAK/STAT3 pathway and PD-L1
Rosanna Di Tinco
;Alessandra Pisciotta
;Giulia Orlandi
;Laura Bertoni
;Elisa Pignatti
;Martina Bonacini
;Cosimo De Bari
;Carlo Salvarani
;Gianluca Carnevale
2026
Abstract
Human Dental Pulp Stromal Cells (hDPSCs) of neural-ectodermal origin hold immunomodulatory properties which make them a source for MSC-based therapies for the treatment of autoimmune diseases. Our results highlighted that hDPSCs exposed to different inflammatory conditions activate Fas/FasL and PD1/PD-L1 pathways. Moreover, hDPSCs modulate inflammatory cytokines release of aPBMCs from Rheumatoid Arthritis (RA) patients. However, the inflammatory milieu induced the upregulation of IL-6 by hDPSCs, which was demonstrated to be strongly correlated to PD-L1 expression, suggesting its involvement in supporting their immunoregulation. Our data demonstrated that the activation of the IL6/JAK/STAT3 trans-signaling pathway in hDPSCs through stimulation with the IL6/sIL6R complex leads to an increase in PD-L1 protein levels, but not PD-L2, via proteasome inhibition. The activation of the IL-6/PD-L1 axis in response to inflammatory conditions underscores its potential significance in autoimmune diseases since a dysfunction of this mechanism could lead to the onset and progression of chronic inflammatory disorders.| File | Dimensione | Formato | |
|---|---|---|---|
|
Data Sheet 1.pdf
Open access
Descrizione: Supplementary data
Tipologia:
VOR - Versione pubblicata dall'editore
Licenza:
[IR] creative-commons
Dimensione
6.28 MB
Formato
Adobe PDF
|
6.28 MB | Adobe PDF | Visualizza/Apri |
|
fimmu-17-1713704.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Licenza:
[IR] creative-commons
Dimensione
7.1 MB
Formato
Adobe PDF
|
7.1 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




